Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$10.78 - $17.73 $95,101 - $156,414
8,822 New
8,822 $105,000
Q3 2022

Nov 14, 2022

SELL
$8.63 - $15.52 $83,745 - $150,606
-9,704 Reduced 5.75%
159,166 $1.41 Million
Q2 2022

Aug 11, 2022

SELL
$8.59 - $20.77 $323,705 - $782,696
-37,684 Reduced 18.24%
168,870 $2.13 Million
Q1 2022

May 13, 2022

BUY
$15.52 - $35.65 $240,466 - $552,361
15,494 Added 8.11%
206,554 $3.91 Million
Q4 2021

Feb 11, 2022

SELL
$28.89 - $35.33 $18,229 - $22,293
-631 Reduced 0.33%
191,060 $6.7 Million
Q3 2021

Nov 04, 2021

BUY
$35.66 - $42.94 $372,219 - $448,207
10,438 Added 5.76%
191,691 $7.02 Million
Q2 2021

Aug 11, 2021

BUY
$23.7 - $39.27 $407,521 - $675,247
17,195 Added 10.48%
181,253 $7.12 Million
Q1 2021

May 13, 2021

SELL
$27.01 - $36.8 $526,559 - $717,416
-19,495 Reduced 10.62%
164,058 $4.63 Million
Q4 2020

Feb 16, 2021

SELL
$27.51 - $34.36 $239,474 - $299,103
-8,705 Reduced 4.53%
183,553 $5.88 Million
Q3 2020

Nov 12, 2020

BUY
$25.8 - $34.61 $851,735 - $1.14 Million
33,013 Added 20.73%
192,258 $6.21 Million
Q2 2020

Aug 13, 2020

BUY
$17.65 - $28.05 $138,676 - $220,388
7,857 Added 5.19%
159,245 $4.39 Million
Q1 2020

May 14, 2020

BUY
$15.19 - $29.51 $124,618 - $242,100
8,204 Added 5.73%
151,388 $2.7 Million
Q4 2019

Feb 14, 2020

SELL
$17.17 - $25.95 $418,896 - $633,102
-24,397 Reduced 14.56%
143,184 $3.59 Million
Q3 2019

Nov 14, 2019

SELL
$17.84 - $22.69 $208,371 - $265,019
-11,680 Reduced 6.52%
167,581 $2.99 Million
Q2 2019

Aug 14, 2019

BUY
$22.0 - $31.78 $840,752 - $1.21 Million
38,216 Added 27.09%
179,261 $3.94 Million
Q1 2019

May 15, 2019

BUY
$21.27 - $30.58 $238,713 - $343,199
11,223 Added 8.64%
141,045 $4.31 Million
Q4 2018

Feb 14, 2019

BUY
$23.09 - $37.69 $2.25 Million - $3.67 Million
97,440 Added 300.91%
129,822 $3 Million
Q3 2018

Nov 14, 2018

BUY
$26.55 - $34.38 $838,502 - $1.09 Million
31,582 Added 3947.75%
32,382 $1.04 Million
Q2 2018

Aug 14, 2018

SELL
$27.79 - $34.49 $1.76 Million - $2.19 Million
-63,433 Reduced 98.75%
800 $24,000
Q1 2018

May 15, 2018

BUY
$28.87 - $41.13 $994,513 - $1.42 Million
34,448 Added 115.66%
64,233 $1.9 Million
Q4 2017

Feb 14, 2018

SELL
$27.41 - $39.42 $1.19 Million - $1.71 Million
-43,282 Reduced 59.24%
29,785 $1.17 Million
Q3 2017

Nov 14, 2017

BUY
$22.15 - $27.5 $1.62 Million - $2.01 Million
73,067
73,067 $1.99 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.